Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor
100%
Clinical Characteristics
100%
Optic Pathway
100%
Pilocytic Astrocytoma
100%
Molecular Characteristics
100%
TBX3
75%
PIM-1
75%
Immunohistochemistry
50%
Transcriptome Analysis
50%
Tumor Progression
50%
PI3K-AKT-mTOR Pathway
50%
Nkx3.2
50%
Transcription Factor
25%
Risk Factors
25%
Protein Kinase
25%
Age at Diagnosis
25%
Young Age
25%
Nave
25%
High Incidence
25%
Male Sex
25%
Clinical Factors
25%
Mitochondrial Genes
25%
CpG Methylation
25%
Mitochondrial Function
25%
RNA Expression
25%
Biological Factors
25%
Downstream Targets
25%
New Targets
25%
Metastasizing
25%
Combination Therapy
25%
Neurofibromatosis Type I
25%
Neurofibromatosis Type 1 (NF-1)
25%
DNA Methylation Analysis
25%
P53 Pathway
25%
Gene Set Enrichment Analysis
25%
Online Treatment
25%
BRAF Fusion
25%
Multiple Therapies
25%
Disease Prognostication
25%
Biochemistry, Genetics and Molecular Biology
TBX3
100%
PIM1
100%
Optics
100%
P53
66%
Tumor Progression
66%
Gene Expression Profiling
66%
Mitogen-Activated Protein Kinase
66%
E2F
66%
Methylation
33%
DNA Methylation
33%
Protein Kinases
33%
RNA
33%
Transcription Factors
33%
Mitochondrial Gene
33%
Protein Kinase B
33%
DnaA
33%
Mammalian Target of Rapamycin
33%
PI3K/AKT/mTOR Pathway
33%
Neuroscience
Pilocytic Astrocytoma
100%
Optics
100%
TBX3
75%
PIM1
75%
Immunohistochemistry
50%
P53
50%
Mitogen-Activated Protein Kinase
50%
Transcriptome
50%
E2F
50%
DNA Methylation
25%
Transcription Factors
25%
Protein Kinases
25%
Mitochondrial Gene
25%
Mitochondrial Function
25%
Protein Kinase B
25%
Neurofibromatosis Type 1
25%
DnaA
25%
PI3K/AKT/mTOR Pathway
25%
Methylation
25%
Risk Factor
25%
Medicine and Dentistry
Tumor
100%
Pilocytic Astrocytoma
100%
Protein P53
50%
Prognostication
50%
Immunohistochemistry
50%
Tumor Progression
50%
Combination Therapy
50%
Gene Expression Profiling
50%
Mitogen-Activated Protein Kinase
50%
Methylation
25%
Transcription Factors
25%
Protein Kinases
25%
Neurofibromatosis Type I
25%
Mitochondrial Gene
25%
Protein Kinase B
25%
DNA Methylation
25%
Mammalian Target of Rapamycin
25%
DNA A
25%
PI3K/AKT/mTOR Pathway
25%
Diseases
25%
Median Follow Up
25%